abstract |
The present invention relates to compounds useful for degrading BTK via the ubiquitin proteolytic pathway. The present invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of various diseases, conditions, or disorders. |